| PACKAGING TYPE: | 10ml C-box |
| COMPOSITION: | Colistimethate Sodium (1million Iu) |
| FORMULATION: | Injection |
| Description: | SODOLISTIM 1 MIU Injection contains Colistimethate Sodium (1 Million IU), a polymyxin antibiotic used as a last-resort therapy for severe infections caused by multidrug-resistant (MDR) gram-negative bacteria. It is particularly effective against organisms like Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae. Colistimethate Sodium works by disrupting the bacterial cell membrane, leading to bacterial cell death. It is primarily used in ICU and critical care settings for life-threatening infections where other antibiotics are ineffective. |
| Side Effects: | Nephrotoxicity (kidney damage) Neurotoxicity (dizziness, weakness, paresthesia) Injection site irritation Respiratory issues (in inhalation use) Rare allergic reactions |
| How to Use: | To be administered only by healthcare professionals Given via IV infusion or inhalation (as per indication) Dosage depends on severity, renal function, and infection type Requires strict monitoring during therapy |
| Precaution: | For hospital/ICU use only Monitor renal function closely Dose adjustment required in renal impairment Avoid concurrent use with other nephrotoxic drugs Use only when clearly indicated (last-resort antibiotic) |
| Product Benefits: | Effective against multidrug-resistant gram-negative bacteria Life-saving antibiotic for critical infections Useful in ventilator-associated pneumonia (VAP) Effective in complicated UTIs and septicemia Last-line therapy for resistant infections Suitab |
Frequently Asked Questions
It is used for severe infections caused by multidrug-resistant bacteria.
Because it is reserved for infections where other antibiotics fail.
Yes, kidney function must be closely monitored during use.












